Literature DB >> 32049016

Discovery of O-Linked Carbohydrate on HIV-1 Envelope and Its Role in Shielding against One Category of Broadly Neutralizing Antibodies.

Zachary A Silver1, Aristotelis Antonopoulos2, Stuart M Haslam2, Anne Dell2, Gordon M Dickinson3, Michael S Seaman4, Ronald C Desrosiers5.   

Abstract

Approximately 50% of the mass of the Envelope (Env) glycoprotein surface subunit (gp120) of human immunodeficiency virus type 1 (HIV-1) is composed of N-linked carbohydrate. Until now, the dogma has been that HIV-1 lacks O-linked carbohydrate on Env. Here we show that a subset of patient-derived HIV-1 isolates contain O-linked carbohydrate on the variable 1 (V1) domain of Env gp120. We demonstrate the presence of this O-glycosylation both on virions and on gp120 expressed as a secreted protein. Further, we establish that these O-linked glycans can confer a more than 1,000-fold decrease in neutralization sensitivity (IC50) to V3-glycan broadly neutralizing antibodies. These findings uncover a structural modification to the HIV-1 Env and suggest a functional role in promoting viral escape from one category of broadly neutralizing antibodies.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Envelope; HIV-1; O-glycosylation; V1 domain; broadly neutralizing antibodies; escape mechanism; gp120; immune evasion

Year:  2020        PMID: 32049016      PMCID: PMC7904042          DOI: 10.1016/j.celrep.2020.01.056

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  29 in total

1.  Binding profile of Artocarpus integrifolia agglutinin (Jacalin).

Authors:  Albert M Wu; June H Wu; Li-Hua Lin; Shin-Hua Lin; Jia-Hau Liu
Journal:  Life Sci       Date:  2003-04-04       Impact factor: 5.037

2.  Elucidation of binding specificity of Jacalin toward O-glycosylated peptides: quantitative analysis by frontal affinity chromatography.

Authors:  Kouichi Tachibana; Sachiko Nakamura; Han Wang; Hiroko Iwasaki; Kahori Tachibana; Kanako Maebara; Lamei Cheng; J Hirabayashi; H Narimatsu
Journal:  Glycobiology       Date:  2005-09-21       Impact factor: 4.313

3.  Human Immunodeficiency Virus and Simian Immunodeficiency Virus Maintain High Levels of Infectivity in the Complete Absence of Mucin-Type O-Glycosylation.

Authors:  James M Termini; Elizabeth S Church; Zachary A Silver; Stuart M Haslam; Anne Dell; Ronald C Desrosiers
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

4.  The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection.

Authors:  Elin S Gray; Maphuti C Madiga; Tandile Hermanus; Penny L Moore; Constantinos Kurt Wibmer; Nancy L Tumba; Lise Werner; Koleka Mlisana; Sengeziwe Sibeko; Carolyn Williamson; Salim S Abdool Karim; Lynn Morris
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

Review 5.  Recent insights into the biological roles of mucin-type O-glycosylation.

Authors:  E Tian; Kelly G Ten Hagen
Journal:  Glycoconj J       Date:  2008-08-10       Impact factor: 2.916

6.  Analysis of saccharide binding to Artocarpus integrifolia lectin reveals specific recognition of T-antigen (beta-D-Gal(1----3)D-GalNAc).

Authors:  M V Sastry; P Banarjee; S R Patanjali; M J Swamy; G V Swarnalatha; A Surolia
Journal:  J Biol Chem       Date:  1986-09-05       Impact factor: 5.157

7.  Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies.

Authors:  Nicole A Doria-Rose; Rachel M Klein; Maura M Manion; Sijy O'Dell; Adhuna Phogat; Bimal Chakrabarti; Claire W Hallahan; Stephen A Migueles; Jens Wrammert; Rafi Ahmed; Martha Nason; Richard T Wyatt; John R Mascola; Mark Connors
Journal:  J Virol       Date:  2008-10-15       Impact factor: 5.103

8.  Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV.

Authors:  Devin Sok; Katie J Doores; Bryan Briney; Khoa M Le; Karen L Saye-Francisco; Alejandra Ramos; Daniel W Kulp; Jean-Philippe Julien; Sergey Menis; Lalinda Wickramasinghe; Michael S Seaman; William R Schief; Ian A Wilson; Pascal Poignard; Dennis R Burton
Journal:  Sci Transl Med       Date:  2014-05-14       Impact factor: 17.956

9.  Structure of the Ebola virus glycoprotein spike within the virion envelope at 11 Å resolution.

Authors:  Daniel R Beniac; Timothy F Booth
Journal:  Sci Rep       Date:  2017-04-11       Impact factor: 4.379

Review 10.  Broadly Neutralizing Antibodies for HIV Eradication.

Authors:  Kathryn E Stephenson; Dan H Barouch
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

View more
  12 in total

Review 1.  Glycomics and glycoproteomics of viruses: Mass spectrometry applications and insights toward structure-function relationships.

Authors:  John F Cipollo; Lisa M Parsons
Journal:  Mass Spectrom Rev       Date:  2020-04-29       Impact factor: 10.946

2.  Analysis of Viral Spike Protein N-Glycosylation Using Ultraviolet Photodissociation Mass Spectrometry.

Authors:  Edwin E Escobar; Shuaishuai Wang; Rupanjan Goswami; Michael B Lanzillotti; Lei Li; Jason S McLellan; Jennifer S Brodbelt
Journal:  Anal Chem       Date:  2022-04-07       Impact factor: 8.008

3.  Impact of Protein Glycosylation on the Design of Viral Vaccines.

Authors:  Kathleen Schön; Bernd Lepenies; Guillaume Goyette-Desjardins
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

Review 4.  HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens.

Authors:  Will Fischer; Elena E Giorgi; Srirupa Chakraborty; Kien Nguyen; Tanmoy Bhattacharya; James Theiler; Pablo A Goloboff; Hyejin Yoon; Werner Abfalterer; Brian T Foley; Houriiyah Tegally; James Emmanuel San; Tulio de Oliveira; Sandrasegaram Gnanakaran; Bette Korber
Journal:  Cell Host Microbe       Date:  2021-06-03       Impact factor: 31.316

Review 5.  A Roadmap for the Molecular Farming of Viral Glycoprotein Vaccines: Engineering Glycosylation and Glycosylation-Directed Folding.

Authors:  Emmanuel Margolin; Max Crispin; Ann Meyers; Ros Chapman; Edward P Rybicki
Journal:  Front Plant Sci       Date:  2020-12-03       Impact factor: 5.753

6.  Does Antigen Glycosylation Impact the HIV-Specific T Cell Immunity?

Authors:  Alex Olvera; Samandhy Cedeño; Anuska Llano; Beatriz Mothe; Jorge Sanchez; Gemma Arsequell; Christian Brander
Journal:  Front Immunol       Date:  2021-01-22       Impact factor: 7.561

7.  Sequential Analysis of the N/O-Glycosylation of Heavily Glycosylated HIV-1 gp120 Using EThcD-sceHCD-MS/MS.

Authors:  Yong Zhang; Shanshan Zheng; Wanjun Zhao; Yonghong Mao; Wei Cao; Wenjuan Zeng; Yueqiu Liu; Liqiang Hu; Meng Gong; Jingqiu Cheng; Younan Chen; Hao Yang
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

Review 8.  Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic.

Authors:  David A Spencer; Mariya B Shapiro; Nancy L Haigwood; Ann J Hessell
Journal:  Front Public Health       Date:  2021-05-26

Review 9.  SARS-CoV-2 variants, spike mutations and immune escape.

Authors:  William T Harvey; Alessandro M Carabelli; Ben Jackson; Ravindra K Gupta; Emma C Thomson; Ewan M Harrison; Catherine Ludden; Richard Reeve; Andrew Rambaut; Sharon J Peacock; David L Robertson
Journal:  Nat Rev Microbiol       Date:  2021-06-01       Impact factor: 78.297

10.  Structural Modifications Controlling Membrane Raft Partitioning and Curvature in Human and Viral Proteins.

Authors:  Deniz Yurtsever; Joseph Helmuth Lorent
Journal:  J Phys Chem B       Date:  2020-08-19       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.